| Literature DB >> 35531184 |
Priya Jarwar1, Yar Muhammad Waryah2, Muhammad Rafiq1, Ali Muhammad Waryah3,4.
Abstract
Background: The purpose of present study was to analyze the association of single nucleotide polymorphism (SNPs) variant in CRYAA and CRYAB genes with Congenital Cataract. Method: Total 196 blood samples of children were collected, out of which 102 samples were congenital cataract (case group) and 94 samples were normal individuals (control group). Genomic DNA was extracted by using optimized inorganic method. Tetra primers for SNPs were designed and TETRA-ARMs assay was performed on both groups. Genotypic, allelic frequency and haplotype analyses were obtained by using SNPstats software.Entities:
Keywords: ARMS assay; Polymerase chain reaction; Single nucleotide polymorphism
Year: 2022 PMID: 35531184 PMCID: PMC9073017 DOI: 10.1016/j.sjbs.2021.12.063
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.052
Primers sequence, product size and annealing temperature of CRYAA and CRYAB genes.
| FI Primer (C allele) | AACGCTCGAGGCGTTACATCGAGGGTAC | Product size for C allele: 198 | 69 °C | ||
| RI Primer (T allele) | CTGGACGCCCAGCCCCATGGCCATAGA | Product size for T allele: 267 | |||
| FO Primer (5′ - 3′) | CAGGGGCCATGGGTCGAGGAGCAAAATA | Product size for two outer primers: 410 | |||
| RO Primer (5′ - 3′) | AAGGTGCCATAATTCCAGCACCTGGGGG | ||||
| FI Primer (G allele) | TCTAACCTCTGTGTCTAACGGGGGTGCGG | Product size for G allele: 151 | 67 °C | ||
| RI Primer (T allele) | CTCATGGTCGCCAGAGGAGGGAGAACA | Product size for T allele: 200 | |||
| FO Primer (5′ - 3′) | GGCACCTTGCAGCTTCTTCTCCACGAGT | Product size for two outer primers: 295 | |||
| RO Primer (5′ - 3′) | CGACAATGGAGCTTCTCATCTGCCAGTCA | ||||
| FI Primer (G allele) | TCTTGCCCAGGCCCGGTGAGACTCTCAG | Product size for G allele: 146 | 67 °C | ||
| RI Primer (C allele) | CGTTAGACACAGAGGTTAGACACATCGACG | Product size for C allele: 193 | |||
| FO Primer (5′ - 3′) | ATAGGGCTCCCCCAGGTGCTGGAATT | Product size for two outer primers: 281 | |||
| RO Primer (5′ - 3′) | ACGTGCCAGGGACCATGCTAGTTCTCTG | ||||
| FI Primer (T allele) | AAGGGCATCTATTTCTTGGGGGCGGT | Product size for T allele: 207 | 67 °C | ||
| RI Primer (C allele) | CCGTGAAGAGAAGCCTGCTGTCAACG | Product size for C allele: 159 | |||
| FO Primer (5′ - 3′) | GCTTGATAATTTGGGCCTGCCCTTAGCAT | Product size for two outer primers: 314 | |||
| RO Primer (5′ - 3′) | CATGGTTTCATCTCCAGGGAGTTCCACA | ||||
| FI Primer (T allele) | TTCTACCTTCGGCCACCCTCCTTCCGGT | Product size for T allele: 227 | 67 °C | ||
| RI Primer (C allele) | GTCCAGTGTCAAACCAGCTGGGTGCACG | Product size for C allele: 169 | |||
| FO Primer (5′ - 3′) | TGGATCCGCCGCCCCTTCTTTCCTTT | Product size for two outer primers: 340 | |||
| RO Primer (5′ - 3′) | AGGTGATGGGGGAGGAAGGCACTAGCAACC | ||||
FI Forward inner, RI Reverse inner, FO forward outer, RO Reverse outer.
Fig. 1Gender distribution of cases of congenital cataract.
Fig. 2The chart represents the number of non-familial congenital cataract affected individuals of different age group.
Fig. 3Gel images of PCR products of CRYAA gene variants showing range of TETRA primers used in ARMS assay. (a) CRYAA rs3761382 homozygous CC 2 bands at 410 and 198 bp (lanes 1, 3), and heterozygous CT 3 bands at 410, 267 and 198 bp (lanes 2, C); (b) CRYAA rs7278468 heterozygous GT 3 bands at 295, 200 and 151 bp (lanes C & 1), homozygous TT 2 bands at 295 and 200 bp (lanes 2,3), and homozygous GG 2 bands at 295 and 151 bp (lane 4); (c) CRYAA rs13053109 heterozygous GC 3 bands at 281, 193 and 146 bp (lanes 1,2), homozygous GG 2 bands at 281 and 146 bp (lane C), and homozygous CC 2 bands at 281 and 193 bp (lanes 3,4).
Fig. 4Gel images of PCR products of CRYAB gene variants showing ranges of TETRA primers used in ARMS assay. (a) CRYAB rs370803064 homozygous CC 2 bands at 314 and 159 (lanes 1,2), and heterozygous CT 3 bands at 314, 207 and 159 (lane C); (b) CRYAB rs387907338 homozygous CC 2 bands at 349 and 169 (lanes C, 1 to 5).
Genotypic and allelic frequencies of CRYAA and CRYAB genes SNPs in congenital cataract.
| N/A | C | 168 (52.1%) | 153 (47.5%) | – | – | |
| T | 34 (48.5%) | 35 (50%) | – | – | ||
| C/C | 67 (53.1%) | 59 (46.8%) | 1 | 0.6 | ||
| C/T | 34 (48.5%) | 35 (50%) | 0.86 (0.48–1.54) | |||
| HWE | ||||||
| G | 88 (48.3%) | 94 (51.6%) | – | – | ||
| T | 114 (55.3%) | 92 (44.6%) | – | – | ||
| Codominant | T/T | 21 (20.8%) | 5 (5.4%) | 1 | ||
| G/T | 72 (71.3%) | 82 (88.2%) | 0.21 (0.07–0.58) | |||
| G/G | 8 (7.9%) | 6 (6.5%) | 0.32 (0.08–1.34) | |||
| Dominant | T/T | 21 (20.8%) | 5 (5.4%) | 1 | ||
| G/T-G/G | 80 (79.2%) | 88 (94.6%) | 0.22 (0.08–0.60) | |||
| Recessive | T/T-G/T | 93 (92.1%) | 87 (93.5%) | 1 | 0.69 | |
| G/G | 8 (7.9%) | 6 (6.5%) | 1.25 (0.42–3.74) | |||
| Over-dominant | T/T-G/G | 29 (28.7%) | 11 (11.8%) | 1 | ||
| T/G | 72 (71.3%) | 82 (88.2%) | 0.33 (0.16–0.71) | |||
| Log-additive | – | – | – | 0.49 (0.25–0.95) | ||
| HWE | – | – | ||||
| G | 169 (51.5%) | 159 (48.4%) | – | – | ||
| C | 33 (51.5%) | 31 (48.4%) | – | – | ||
| Codominant | G/G | 75 (74.3%) | 66 (69.5%) | 1 | 0.094 | |
| G/C | 19 (18.8%) | 27 (28.4%) | 0.62 (0.32–1.21) | |||
| C/C | 7 (6.9%) | 2 (2.1%) | 3.08 (0.62–15.35) | |||
| Dominant | G/G | 75 (74.3%) | 66 (69.5%) | 1 | 0.46 | |
| G/C-C/C | 26 (25.7%) | 29 (30.5%) | 0.79 (0.42–1.47) | |||
| Recessive | G/G-G/C | 94 (93.1%) | 93 (97.9%) | 1 | 0.096 | |
| C/C | 7 (6.9%) | 2 (2.1%) | 3.46 (0.70–17.11) | |||
| Over-dominant | G/G-C/C | 82 (81.2%) | 68 (71.6%) | 1 | 0.11 | |
| G/C | 19 (18.8%) | 27 (28.4%) | 0.58 (0.30–1.14) | |||
| Log-additive | – | – | – | 1.00 (0.61–1.65) | 1 | |
| HWE | – | – | ||||
| N/A | C | 101 (34%) | 190 (64%) | – | – | |
| T | 101 (100%) | 0 (0%) | – | – | ||
| C/C | 95 (100%) | 0 (0%) | ||||
| C/T | 0 (0%) | 101 (100%) | ||||
| HWE | – | – | ||||
| N/A | C | 202 (50.7%) | 190 (47.7%) | – | – | |
| C/C | 101 (50.7%) | 95 (47.7%) | – | – | ||
| HWE | – | – | – | – | ||
Haplotype analyses for three SNPs in CRYAA gene.
| 1 | C | T | G | 0.4448 | 0.3236 | 0.3985 | 1 | – |
| 2 | C | G | G | 0.2402 | 0.3448 | 0.2797 | 0.34 (0.14–0.84) | 0.02 |
| 3 | C | G | C | 0.1219 | 0.1279 | 0.1238 | 0.41 (0.15–1.09) | 0.075 |
| 4 | T | T | G | 0.0908 | 0.1372 | 0.1042 | 0.56 (0.20–1.56) | 0.27 |
| 5 | T | G | G | 0.0608 | 0.0311 | 0.0543 | 0.86 (0.13–5.92) | 0.88 |
| 6 | C | T | C | 0.0247 | 0.0176 | 0.0212 | 1.60 (0.11–22.64) | 0.73 |
CI = Confidence interval, OR = Odds ratio, SNP = Single nucleotide polymorphism.